Immunohistochemical and clinicopathological correlation of the metastasis-associated gene 1 (MTA1) expression in benign and malignant pancreatic endocrine tumors

Modern Pathology

Volumn 22, Issue 7, 2009, Pages 933-939

  Hofer, Matthias D ^a,b   Chang, Martin C ^a,b   Hirko, Kelly A ^a   Rubin, Mark A ^a,b   Nosé, Vnia ^a,b  

^a BRIGHAM AND WOMEN S HOSPITAL   (United States)

^b HARVARD MEDICAL SCHOOL   (United States)

Author keywords

Biomarker; Malignancy; Metastasis; Metastasis associated gene 1; MTA1; Pancreatic endocrine tumor

Indexed keywords

BIOLOGICAL MARKER;

ADULT; AGED; ARTICLE; CANCER GROWTH; CLINICAL ARTICLE; FEMALE; GENE EXPRESSION; GENETIC ASSOCIATION; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MALE; MALIGNANT TRANSFORMATION; METASTASIS ASSOCIATED GENE 1; MITOSIS; PANCREAS ISLET CELL TUMOR; PRIORITY JOURNAL; TUMOR GENE;

ADENOMA, ISLET CELL; ADULT; AGED; AGED, 80 AND OVER; CARCINOMA, ISLET CELL; FEMALE; FLUORESCENT ANTIBODY TECHNIQUE, INDIRECT; HISTONE DEACETYLASES; HUMANS; IMMUNOENZYME TECHNIQUES; ISLETS OF LANGERHANS; MALE; MIDDLE AGED; NEOPLASM INVASIVENESS; PANCREATIC NEOPLASMS; REPRESSOR PROTEINS; RETROSPECTIVE STUDIES; TUMOR MARKERS, BIOLOGICAL;

EID: 67650673264     PISSN: 08933952     EISSN: 15300285     Source Type: Journal    
DOI: 10.1038/modpathol.2009.50     Document Type: Article

References (14)

1. Xue Y, Wong J, Moreno GT, et al. NURD, a novel complex with both ATP-dependent chromatin-remodeling and histone deacetylase activities. Mol Cell 1998;2:851-861.
2. Zhang XY, DeSalle LM, Patel JH, et al. Metastasisassociated protein 1 (MTA1) is an essential downstream effector of the c-MYC oncoprotein. Proc Natl Acad Sci USA 2005;102:13968-13973.
3. Hofer MD, Menke A, Genze F, et al. Expression of MTA1 promotes motility and invasiveness of PANC-1 pancreatic carcinoma cells. Br J Cancer 2004;90: 455-462.
4. Mahoney MG, Simpson A, Jost M, et al. Metastasisassociated protein (MTA)1 enhances migration, invasion, and anchorage-independent survival of immortalized human keratinocytes. Oncogene 2002;21: 2161-2170.
5. Hofer MD, Kuefer R, Varambally S, et al. The role of metastasis-associated protein 1 in prostate cancer progression. Cancer Res 2004;64:825-829.
6. Jang KS, Paik SS, Chung H, et al. MTA1 overexpression correlates significantly with tumor grade and angiogenesis in human breast cancers. Cancer Sci 2006;97:374-379.
7. Toh Y, Kuwano H, Mori M, et al. Overexpression of metastasis-associated MTA1 mRNA in invasive oesophageal carcinomas. Br J Cancer 1999;79:1723-1726.
8. Toh Y, Oki E, Oda S, et al. Overexpression of the MTA1 gene in gastrointestinal carcinomas: correlation with invasion and metastasis. Int J Cancer 1997;74:459-463.
9. Hofer MD, Tapia C, Browne TJ, et al. Comprehensive analysis of the expression of the metastasis-associated gene 1 in human neoplastic tissue. Arch Pathol Lab Med 2006;130:989-996.
10. Lugli A, Forster Y, Haas P, et al. Calretinin expression in human normal and neoplastic tissues: a tissue microarray analysis on 5233 tissue samples. Hum Pathol 2003;34:994-1000.
11. Went PT, Lugli A, Meier S, et al. Frequent EpCam protein expression in human carcinomas. Hum Pathol 2004;35:122-128.
12. Chang MC, Xiao S, Nose V. Clinicopathologic and immunohistochemical correlation in sporadic pancreatic endocrine tumors: possible roles of utrophin and cyclin D1 in malignant progression. Hum Pathol 2007;38:732-740.
13. Toh Y, Pencil SD, Nicolson GL. A novel candidate metastasis-associated gene, mta1, differentially expressed in highly metastatic mammary adenocarcinoma cell lines. cDNA cloning, expression, and protein analyses. J Biol Chem 1994;269:22958-22963.
14. Mazumdar A, Wang RA, Mishra SK, et al. Transcriptional repression of oestrogen receptor by metastasisassociated protein 1 corepressor. Nat Cell Biol 2001;3: 30-37.